Importance Eating disorders are characterized by disturbances in eating behavior and occur worldwide, with a lifetime prevalence of 2% to 5%. They are more common among females than males and may be associated with medical and psychiatric complications, impaired functioning, and…
This JAMA Insights discusses the need to fully assimilate evidence from observed and projected effects of climate change on health and invest in developing and implementing effective health protection from preventable climate-sensitive conditions.
Importance Prostate cancer is the most common nonskin cancer in men in the US, with an estimated 299 010 new cases and 35 250 deaths in 2024. Prostate cancer is the second most common cancer in men worldwide, with 1 466 680 new cases and…
This JAMA Insights investigates the adverse effects of food insecurity on health and how federal nutrition programs can help mitigate these effects, improving health outcomes and reducing health care utilization.
Importance An estimated 12.8% of US households experienced food insecurity in 2022. Objective To review the evidence on benefits and harms of screening and interventions for food insecurity in health care settings. Data Sources MEDLINE, CINAHL, and the Cochrane Central Registry of Controlled…
Importance According to survey data, 12.8% of households experienced food insecurity in 2022, with 7.7% of households experiencing low food security and 5.1% experiencing very low food security. Nearly one-third of households with incomes below the federal poverty threshold are food…
This JAMA Insights discusses the US Food and Drug Administration approval of Kebilidi, eladocagene exuparvovec, for the treatment of aromatic L-amino acid decarboxylase deficiency in adult and pediatric patients.
This JAMA Insights explores the use of portable point-of-care ultrasound and focused cardiac ultrasound imaging in the diagnosis and treatment of patients with sepsis and septic shock in the emergency department and intensive care unit.
Importance Chronic myeloid leukemia (CML) has an annual incidence of 2 cases per 100 000 people and is newly diagnosed in approximately 9300 individuals per year in the US. Approximately 150 000 people in the US and 5 million worldwide have CML. Observations Chronic…
This JAMA Insights discusses how physicians can engage in successful clinical negotiation if a patient requests a test or treatment that is deemed inappropriate, potentially harmful, or low-value.
© 2026
American Board of Medical Specialties | Policies | Sitemap | Terms of Use | www.abms.org
